+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Familial Adenomatous Polyposis Coli - Pipeline Insight, 2025 - Product Thumbnail Image

Familial Adenomatous Polyposis Coli - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-Lymphotoxin - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-Lymphotoxin - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD80 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD80 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD52 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD52 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD40 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD40 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD37 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD37 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Papillary Thyroid Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Papillary Thyroid Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Endocrine Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Endocrine Tumor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
Thyroid Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Thymus Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Thymus Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD33 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD33 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Anti-CD19 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD19 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD152 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD152 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti GM-CSF Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti GM-CSF Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Biliary Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Biliary Tumor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Anaplastic Large Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Anaplastic Large Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatic Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatic Tumor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more